{"sourcedb":"DevicePMAs@therightstef","sourceid":"P140003_S005","text":"Approval for the Impella 2.5, Impella CP, Impella 5.0, and Impella LD catheters, in conjunction with the Automated Impella Controller, are temporary ventricular support devices intended for short term use (\u003C= 4 days for the Impella 2.5 and Impella CP, and \u003C=6 days for Impella 5.0 and LD) and indicated for the treatment of ongoing cardiogenic shock that occurs immediately (\u003C48 hours) following acute myocardial infarction or open heart surgery as a result of isolated left ventricular failure that is not responsive to optimal medical management and conventional treatment measures.* The intent of the Impella system therapy is to reduce ventricular work and to provide the circulatory support necessary to allow heart recovery and early assessment of residual myocardial function.*optimal medical management and conventional treatment measures include volume loading and use of pressors and inotropes, with or without IABP.","project":"consensus_PMA_Age_Indications"}